Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CNXN | SVM |
|---|---|---|
| Price | $92.40 | $10.55 |
| Change today | ▲ 0.02% | ▼ 0.28% |
| Market cap | $2.33B | $2.33B |
| Return, 3 months | +24.7% | +12.6% |
| Return, year to date | +61.4% | +26.6% |
| Return, 1 year | +56.3% | +47.5% |
| P/E (TTM) | 24.4 | 95.9 |
| P/B | 2.4 | 2.4 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | 0.76% | 0.24% |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | – | +37.3% |
| Analyst buy share | – | 100% |
| RSI (14) | 76 | 38 |
| 30-day volatility | 22.1% | 55.1% |
| Max drawdown, 1 year | -16.9% | -43.8% |
| Trend read | Strong uptrend | Strong downtrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
